Loading...
Please wait, while we are loading the content...
Similar Documents
Does the use of paclitaxel or rapamycin-eluting stent decrease further need for coronary-artery bypass grafting when compared with bare-metal stent?
| Content Provider | Semantic Scholar |
|---|---|
| Author | Lemos, Hernani Pinto De Atallah, Alvaro Nagib |
| Copyright Year | 2007 |
| Abstract | CONTEXT AND OBJECTIVE The safety and efficacy of drug-eluting stents reduce the need for surgical revascularization. The objective of the present study was to investigate whether paclitaxel or rapamycin-eluting stent are effective in avoiding the need for coronary-artery bypass grafting. METHODS This was a systematic review of the literature using the methodology of the Cochrane Collaboration. The type of study considered was controlled randomized trials; the type of intervention was drug-eluting or bare-metal stents; and the main outcome investigated was coronary-artery bypass grafting. RESULTS The ten studies included in this systematic review did not show any statistically significant difference between the drug-eluting stents and the bare-metal stents with regard to the outcome of coronary-artery bypass grafting (confidence interval: 0.31 to 1.42). CONCLUSION The surgical revascularization rate was not reduced by the use of drug-eluting stents. |
| Starting Page | 1 |
| Ending Page | 6 |
| Page Count | 6 |
| File Format | PDF HTM / HTML |
| Alternate Webpage(s) | http://www.scielo.br/pdf/spmj/v125n4/v125n4a10.pdf |
| PubMed reference number | 17992397v1 |
| Volume Number | 125 |
| Issue Number | 4 |
| Journal | Sao Paulo medical journal = Revista paulista de medicina |
| Language | English |
| Access Restriction | Open |
| Subject Keyword | Confidence Intervals Drug-Eluting Stents Paclitaxel Sirolimus Stent Device Component Stent, device Transplanted tissue bypass revascularization |
| Content Type | Text |
| Resource Type | Article |